Fanconi Anemia Market Growth Driven by Genetic Research and Healthcare Investments**Fanconi Anemia (FA) is a rare genetic disorder impacting bone marrow's ability to produce blood cells, leading to ...

According to research by SNS Insider, the U.S. Preimplantation Genetic Testing Market will reach USD 528.43 million by 2032, driven by rising IVF cycle volumes, increased awareness of genetic ...

Fred Hutch bioengineer Dr. Matthias Stephan is working to develop a special foam that could help make gene therapy for blood ...

As much as the focus for Suárez shifted to picking out his equally talented teammates, he still found plenty of time to shoot ...

Non-exclusive license providing Solid’s proprietary, next-generation capsid, AAV-SLB101, to Andelyn Biosciences, a full-service cell and gene therapy Contract Development and Manufacturing ...